RA Capital Management, L.P. 13D/13G Filings for Sutro Biopharma, Inc. (STRO)

RA Capital Management, L.P. 13D and 13G filings for Sutro Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-04-04
4:32 pm
Purchase
2025-03-2813GSutro Biopharma, Inc.
STRO
RA Capital Management, L.P.4,434,637
5.300%
4,434,637increase
(New Position)
Filing